Zenapax (Daclizumab)

General Details:

Name:
Zenapax (Daclizumab)
Steward:
NHLBI
Definition:
Code indicating whether Zenapax (Daclizumab) therapy was used to treat chronic GVHD (graft-versus-host disease)
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Yes Yes
No No

Designations:

Designation:
Zenapax (Daclizumab)
Tags:
Designation:
Zenapax therapy chronic GVHD indicate code
Tags:
Preferred Question Text

Designations:

Definition:
Code indicating whether Zenapax (Daclizumab) therapy was used to treat chronic GVHD (graft-versus-host disease)
Tags:
Short Description,Description

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
en-us
Document:

Properties:

Key:
Guidelines/Instructions
Value:
SCKLCELL: Indicate whether the agent listed was used to treat chronic GVHD during this assessment period ----- SCKLCELL: Indicate whether the agent listed was used to treat chronic GVHD during this assessment period

Identifiers:

Source:
NLM
Id:
EOb7zPjKJp
Version:
Source:
BRICS Variable Name
Id:
ZenapaxThpyChrnGVHDIndCode
Version:
Source:
NHLBI ID
Id:
C58912
Version: